USP Opens Site in Brazil

SAO PAULO, Brazil—The U.S. Pharmacopeial (USP) Convention, Rockville, Md., opened its newest international site, located in the WTorre Technology Park, São Paulo, Brazil. The USP-Brazil facility supports USP’s international public health mission to improve the health of people around the world through public standards and related programs that help ensure the quality and safety of medicines and foods.

“This new site demonstrates USP’s commitment to ensuring the quality and safety of pharmaceuticals, dietary supplements and food ingredients for everyone, regardless of geographic, economic or political borders,” said Roger L. Williams, executive vice president and CEO, USP. “As the world continues to focus on these issues, it is even more important for standards-setting bodies and governments to collaborate. This office and laboratory facility will help USP work with Brazilian regulators and manufacturers to move toward that goal.”

Flavio Vormittag, vice president, international-Brazil, added: “USP-Brazil will work closely with ANVISA, the Brazilian Pharmacopeia, Febrafarma and other organizations to help ensure the quality of medicines and food ingredients and better serve our customers. Our presence will benefit Brazilian manufacturers, government agencies and ultimately patients in Brazil, the U.S., and the many countries to which Brazil exports.”

The new facility, which is approximately 1,800 square meters, has both state-of-the-art office and laboratory space, and is ideally located near many of USP’s key pharmaceutical clients. Vormittag oversees the facility and is currently hiring staff to begin operations.